[Form 4] PRECIGEN, INC. Insider Trading Activity

Rhea-AI Filing Summary

PRECIGEN, Inc. (PGEN) Form 4: Director Jeffrey B. Kindler reported two separate sales of company common stock. On 09/29/2025 he sold 67,523 shares at a weighted-average price of $3.60, and on 09/30/2025 he sold 106,837 shares at a weighted-average price of $3.38. Following the 09/29/2025 sale his beneficial ownership in the reported class was 452,907 shares (direct). Following the 09/30/2025 sale his beneficial ownership was 346,070 shares (direct). The form includes explanatory footnotes that the reported prices are weighted averages across multiple transactions and that the filer will provide details on request. The Form 4 is signed by Jeffrey B. Kindler by attorney-in-fact Donald P. Lehr.

Positive

• Transactions properly disclosed with dates, amounts, weighted-average prices, and post-transaction beneficial ownership figures
• Explanatory footnotes commit to provide detailed per-price breakdowns upon request, enhancing transparency
• Form signed (by attorney-in-fact), indicating executed and submitted disclosure

Negative

• None.

Insights

Financial Analyst

TL;DR Insider director sold material share blocks across two days; holdings declined to 346,070 shares.

The filings show direct sales of 67,523 and 106,837 shares on consecutive days at weighted-average prices of $3.60 and $3.38 respectively, reducing the reporting person's direct holdings to 346,070 shares. The disclosure is complete with footnotes clarifying that prices are weighted averages across multiple transactions and that detailed price-by-price breakdowns are available on request. The transactions are reported on separate lines and the Form 4 is signed via power of attorney.

Corporate Governance Expert

TL;DR Director-level insider sales properly disclosed; signature executed by attorney-in-fact.

The Form 4 indicates compliance with Section 16 reporting: the reporter is identified as a director, transactions are dated and priced with explanatory footnotes, and the submission is signed by an attorney-in-fact. There is no derivative activity reported. The filing supplies the required post-transaction beneficial ownership figures, supporting transparency of the director's ownership changes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

KINDLER JEFFREY B

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MD 20876

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/29/2025		S		67,523	D	$3.6(1)	452,907	D
Common Stock	09/30/2025		S		106,837	D	$3.38(2)	346,070	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.5700 to $3.6350, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission (SEC), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

2. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.3500 to $3.4250, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

	/s/ Jeffrey B. Kindler, by Donald P. Lehr, as attorney-in-fact	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Jeffrey B. Kindler report for PGEN?

He reported selling 67,523 shares on 09/29/2025 at a weighted-average price of $3.60 and 106,837 shares on 09/30/2025 at a weighted-average price of $3.38.

How many PGEN shares did the reporting person own after these transactions?

After the 09/29/2025 sale the reporting person owned 452,907 shares (direct). After the 09/30/2025 sale the reporting person owned 346,070 shares (direct).

Were the reported sale prices exact or averages?

The Form 4 states the reported prices are weighted-average prices across multiple transactions, with price ranges provided in footnotes.

Did the Form 4 report any derivative transactions or options?

No. Table II for derivative securities contains no entries; only non-derivative common stock sales are reported.

Who signed the Form 4 and how?

The Form 4 is signed /s/ Jeffrey B. Kindler, by Donald P. Lehr, as attorney-in-fact and dated 10/01/2025.